Rebound syndrome after teriflunomide cessation in a patient with multiple sclerosis

Immune Reconstitution Inflammatory Syndrome and Rebound Syndrome on Withdrawal of Immunomodulatory Drugs for Multiple Sclerosis: Current Understanding and a Case Report

Neuroscience and Behavioral Physiology ◽

10.1007/s11055-018-0619-z ◽

2018 ◽

Vol 48 (6) ◽

pp. 693-702 ◽

Author(s):

A. N. Belova ◽

M. V. Rasteryaeva ◽

N. I. Zhulina ◽

E. M. Belova ◽

A. N. Boiko

Keyword(s):

Multiple Sclerosis ◽

Case Report ◽

Immune Reconstitution Inflammatory Syndrome ◽

Immune Reconstitution ◽

Current Understanding ◽

Immunomodulatory Drugs ◽

Inflammatory Syndrome ◽

Fingolimod cessation and multiple sclerosis rebound syndrome: a case report and literature review

10.26226/morressier.5b719e475aff74008ae4cd0e ◽

2018 ◽

Author(s):

Giordani Rodrigues dos Passos

Keyword(s):

Multiple Sclerosis ◽

Case Report ◽

Literature Review ◽

Immune reconstitution inflammatory syndrome and rebound syndrome in multiple sclerosis patients who stopped disease modification therapy: current understanding and a case report

Zhurnal nevrologii i psikhiatrii im S S Korsakova ◽

10.17116/jnevro20171172274-84 ◽

2017 ◽

Vol 117 (2. Vyp. 2) ◽

pp. 74 ◽

Author(s):

A. N. Belova ◽

M. V. Rasteryaeva ◽

N. I. Zhulina ◽

E. M. Belova ◽

A. N. Boyko

Keyword(s):

Multiple Sclerosis ◽

Case Report ◽

Immune Reconstitution Inflammatory Syndrome ◽

Immune Reconstitution ◽

Current Understanding ◽

Disease Modification ◽

Multiple Sclerosis Patients ◽

Inflammatory Syndrome ◽

Debate on the treatment of multiple sclerosis: Experience from an intractable multiple sclerosis case with rebound syndrome after fingolimod cessation

Clinical and Experimental Neuroimmunology ◽

10.1111/cen3.12504 ◽

2019 ◽

Vol 10 (S1) ◽

pp. 59-62 ◽

Author(s):

Hiroshi Kuroda ◽

Shuhei Nishiyama ◽

Yuki Matsumoto ◽

Tatsuro Misu ◽

Kazuo Fujihara ◽

...

Keyword(s):

Multiple Sclerosis ◽

Multiple Sclerosis Case ◽

Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation

JAMA Neurology ◽

10.1001/jamaneurol.2016.3199 ◽

2016 ◽

Vol 73 (11) ◽

pp. 1375 ◽

Cited By ~ 3

Author(s):

Martin Merschhemke ◽

Davorka Tomic ◽

Norman Putzki

Keyword(s):

Multiple Sclerosis ◽

Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation—Reply

JAMA Neurology ◽

10.1001/jamaneurol.2016.3202 ◽

2016 ◽

Vol 73 (11) ◽

pp. 1376 ◽

Author(s):

Stacy Ellen Hatcher ◽

Emmanuelle Waubant ◽

Jennifer S. Graves

Keyword(s):

Multiple Sclerosis ◽

Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment

JAMA Neurology ◽

10.1001/jamaneurol.2016.0826 ◽

2016 ◽

Vol 73 (7) ◽

pp. 790 ◽

Cited By ~ 91

Author(s):

Stacy Ellen Hatcher ◽

Emmanuelle Waubant ◽

Bardia Nourbakhsh ◽

Elizabeth Crabtree-Hartman ◽

Jennifer S. Graves

Keyword(s):

Multiple Sclerosis ◽

Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation

JAMA Neurology ◽

10.1001/jamaneurol.2016.3507 ◽

2016 ◽

Vol 73 (11) ◽

pp. 1375 ◽

Cited By ~ 2

Author(s):

Chittaranjan Andrade

Keyword(s):

Multiple Sclerosis ◽

Management of Multiple Sclerosis

Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders ◽

10.1044/nnsld10.2.4 ◽

2000 ◽

Vol 10 (2) ◽

pp. 4-11

Author(s):

Francois A. Bethoux

Keyword(s):

Multiple Sclerosis

Microglia-derived macrophages in early multiple sclerosis plaques

Neuropathology and Applied Neurobiology ◽

10.1046/j.1365-2990.1996.3798037.x ◽

1996 ◽

Vol 22 (3) ◽

pp. 207-215 ◽

Cited By ~ 7

Author(s):

H. Li ◽

M. L. Cuzner ◽

J. Newcombe

Keyword(s):

Multiple Sclerosis